中心対称(C₄H₈N₅)(SbF₄)から極性(C₄H₇N₄O)(SbF₄)へ:官能基変調により達成された新しいUV非線形光学材料
Zhi-Xiang Wang1,2, Chun-Li Hu1, Chuan-Fu Sun3
1State Key Laboratory of Functional Crystals and Devices, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences Fuzhou 350002 P. R. China kongfang@fjirsm.ac.cn.
Chemical science
|February 11, 2026
まとめ
研究者らは、有機および無機成分を配置することにより、新しい紫外線非線形光学(NLO)材料を開発した。極性材料(C4H7N4O)(SbF4)は、強い第二高調波発生(SHG)と広いバンドギャップを示す。
科学分野:
- 材料科学;固体化学;オプトエレクトロニクス
背景:
- 紫外線非線形光学(NLO)材料の設計は、NLO効率と光学バンドギャップのトレードオフのため困難である。;有機無機ハイブリッド材料は、NLO用途向けに調整可能な特性を提供する。
研究 の 目的:
- 紫外線NLO用途向けに新しい有機無機ハイブリッドフッ化アンチモン酸塩を合成および特性評価すること。;分子配列とNLO特性の関係を調査すること。
主な方法:
- π共役有機カチオンと[SbF4]-アニオンを組み立てるために、官能基変調戦略を採用した。;2つの新しい化合物、(C4H8N5)(SbF4)と(C4H7N4O)(SbF4)を合成した。;第二高調波発生(SHG)効果、光学バンドギャップ、および位相整合可能波長を測定した。
主要な成果:
- 極性化合物(C4H7N4O)(SbF4)は、広いバンドギャップ(4.40 eV)と短い位相整合可能波長(263 nm)で強いSHG効果(4.2×KDP)を示した。;このSHG強度は、光学バンドギャップ>4.20 eVのハイブリッドパーフルオロアンチモン酸塩で報告されている中で最高である。;NLO性能は主に、平行に配置された有機基(寄与率89.49%)に起因すると考えられる。
結論:
- π共役有機配位子の配列は、水素結合ドナーを調整することによって平行配向を達成するように制御できる。;官能基変調は、広いバンドギャップと強いNLO応答を持つ高度な紫外線NLO材料を設計するための効果的な戦略である。
関連する概念動画
Nonlinear Pharmacokinetics: Causes of Nonlinearity
744
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
744
Group Polarization
39.2K
Group polarization is the strengthening of an original group attitude following the discussion of views within a group (Teger & Pruitt, 1967). That is, if a group initially favors a viewpoint, after discussion the group consensus is likely a stronger endorsement of the viewpoint. Conversely, if the group was initially opposed to a viewpoint, group discussion would likely lead to stronger opposition.
39.2K
Molecular Shape and Polarity
76.0K
Dipole Moment of a Molecule
76.0K
Application of Nonlinear Inequalities
266
A nonlinear inequality describes a comparison involving an expression that curves or behaves more complexly than a straight line. These inequalities often appear in forms that include squares, products, or variables in the denominator.To solve such an inequality, one starts by rewriting it so that zero appears on one side. For example, the inequality: can be factored as: This form makes it easier to identify the values that cause the expression to equal zero. In this case, the...
266
Introduction to Nonlinear Inequalities
234
Linear and nonlinear inequalities are fundamental for analyzing variable relationships and identifying ranges satisfying specific conditions. A linear inequality involves variables raised only to the first power, resulting in a straight-line graph. This line partitions the coordinate plane into two distinct regions: one that satisfies the inequality and one that does not. Each region represents a set of solutions where the linear relationship holds true under the specified constraint.Nonlinear...
234
Nonlinear Pharmacokinetics: Overview
1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K


